Announced Sat, 25 Jul · 17:09 IST
NCLT advances Laurus Labs composite scheme, next hearing Sept 10
LAURUSLABS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
—1-day move
₹1605.80
prior close
₹1624.80
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+1.6+2.2+2.4+1.5——————————
Up moveDown movePending
AI summary
Laurus Labs informed exchanges that NCLT has directed petitioner companies to serve hearing notice in Form CAA-3 to regulators for the composite scheme of arrangement. The scheme involves demerger of Unit-1 of wholly-owned subsidiary Laurus Synthesis into another wholly-owned subsidiary Sriam Labs, and amalgamation of the remaining LSPL with Laurus Labs. Next hearing is September 10, 2026. Since all entities are wholly-owned, this is internal restructuring.
Likely market impact
Internal restructuring between wholly-owned subsidiaries; no immediate impact on minority shareholders. NCLT progress is a procedural positive.